CD27 and plasma cell myeloma: Moreover, CD27 activates both the classical and alternative nuclear factor-κB pathways and the under-expression of CD27 in CD-1 myeloma subgroup is reported to be associated with a lower NF-κB signature when compared to CD-2 myeloma subgroup [19, 20].